* If the product has intellectual property rights, a license granted is must or contact us.
基本信息 |
|
产品名称: | 瑞格列奈 |
CAS: | 135062-02-1 ;108157-52-4 |
中文同义词: | 瑞格列奈 |
英文同义词: | 2-ETHOXY-4-([(S)-3-METHYL-1-(2-PIPERIDIN-1-YL-PHENYL)-BUTYLCARBAMOYL]-METHYL)-BENZOIC ACID ; (S)-(+)-2-ETHOXY-4-[N-[1-(2-PIPERIDINOPHENYL)-3-METHYL-1-BUTYL]AMINOCARBONYLMETHYL]BENZOIC ACID ; BENZOIC ACID, 2-ETHOXY-4-[2-[[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]- ; RAPAGLINIDE ; PRANDIN ; GLUCONORM ; S-(+)-2-ETHOXY-4-[2-(3-METHYL-1-[2-(PIPERIDIN-1-YL)PHENYL]BUTYLAMINO)-2-OXOETHYL]BENZOIC ACID ; (S)-2-ETHOXY-4-(2-(3-METHYL-1-(2-(PIPERIDIN-1-YL)PHENYL)BUTYLAMINO)-2-OXOETHYL)BENZOIC ACID ; AG-EE-623 ; REPAGLINIDE ; AG-EE 623ZW ; (S)-2-ETHOXY-4-[2-[[[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]BENZOIC ACID ; 2-ETHOXY-4-[2-[[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID ; NOVONORM ; 2-ETHOXY-4-[2-[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID |
MDL号: | MFCD00906179 |
氢键受体数量: | 6 |
氢键供体数量: | 2 |
Smile: | CCOc1cc(ccc1C(=O)O)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3 |
InChi: | InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 |
InChiKey: | InChIKey=FAEKWTJYAYMJKF-QHCPKHFHSA-N |
性质 |
|
注解: | OTHER NOTES: SALES RESTRICTIONS MAY APPLY BIOCHEM/PHYSIOL ACTIONS: REPAGLINIDE IS A POTENT SHORT-ACTING INSULIN SECRETAGOGUE THAT ACTS BY CLOSING ATP-SENSITIVE POTASSIUM (KATP) CHANNELS IN THE PLASMA MEMBRANE OF THE PANCREATIC BETA CELL. IT REPRESENTS A NEW CLASS OF INSULIN SECRETAGOGUES, STRUCTURALLY UNRELATED TO SULPHONYLUREAS, WHICH WERE DEVELOPED FOR THE TREATMENT OF TYPE 2 DIABETES GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA |
安全信息 |
|
WGK德国: | 2 |
* If the product has intellectual property rights, a license granted is must or contact us.